What if developing a vaccine was the easy part?
Today, Explained
00:00
Intro
This chapter explores the advancements in COVID-19 vaccinations, focusing on Moderna's phase 3 trial results that show an efficacy of 94%. It reflects on the rapid development of vaccines and the hopeful implications for overcoming the pandemic.
Play episode from 00:00
Transcript
